Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of BRL 781.60 billion. The enterprise value is 1.03 trillion.

Market Cap	781.60B
Enterprise Value	1.03T

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	May 8, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.97%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.68B

Valuation Ratios

The trailing PE ratio is 17.18 and the forward PE ratio is 8.92.

PE Ratio	17.18
Forward PE	8.92
PS Ratio	2.17
PB Ratio	1.49
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.68, with an EV/FCF ratio of 15.87.

EV / Earnings	22.59
EV / Sales	3.04
EV / EBITDA	7.68
EV / EBIT	11.40
EV / FCF	15.87

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.69.

Current Ratio	1.26
Quick Ratio	0.88
Debt / Equity	0.69
Debt / EBITDA	2.55
Debt / FCF	5.56
Interest Coverage	5.57

Financial Efficiency

Return on equity (ROE) is 8.62% and return on invested capital (ROIC) is 6.52%.

Return on Equity (ROE)	8.62%
Return on Assets (ROA)	4.79%
Return on Invested Capital (ROIC)	6.52%
Return on Capital Employed (ROCE)	9.58%
Revenue Per Employee	4.45M
Profits Per Employee	561,523
Employee Count	81,000
Asset Turnover	0.29
Inventory Turnover	1.47

Taxes

Income Tax	-2.94B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.97% in the last 52 weeks. The beta is 0.49, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	-8.97%
50-Day Moving Average	33.08
200-Day Moving Average	37.08
Relative Strength Index (RSI)	65.18
Average Volume (20 Days)	7,008

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.31

Income Statement

In the last 12 months, Pfizer had revenue of BRL 360.40 billion and earned 45.48 billion in profits. Earnings per share was 7.98.

Revenue	360.40B
Gross Profit	268.23B
Operating Income	94.88B
Pretax Income	42.62B
Net Income	45.48B
EBITDA	134.56B
EBIT	94.88B
Earnings Per Share (EPS)	7.98

Full Income Statement

Balance Sheet

The company has 99.93 billion in cash and 360.02 billion in debt, giving a net cash position of -260.09 billion.

Cash & Cash Equivalents	99.93B
Total Debt	360.02B
Net Cash	-260.09B
Net Cash Per Share	n/a
Equity (Book Value)	522.96B
Book Value Per Share	91.69
Working Capital	54.29B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 80.71 billion and capital expenditures -15.98 billion, giving a free cash flow of 64.74 billion.

Operating Cash Flow	80.71B
Capital Expenditures	-15.98B
Free Cash Flow	64.74B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.42%, with operating and profit margins of 26.33% and 12.62%.

Gross Margin	74.42%
Operating Margin	26.33%
Pretax Margin	11.82%
Profit Margin	12.62%
EBITDA Margin	37.34%
EBIT Margin	26.33%
FCF Margin	17.96%

Dividends & Yields

This stock pays an annual dividend of 1.65, which amounts to a dividend yield of 4.71%.

Dividend Per Share	1.65
Dividend Yield	4.71%
Dividend Growth (YoY)	16.10%
Years of Dividend Growth	1
Payout Ratio	20.72%
Buyback Yield	-0.97%
Shareholder Yield	3.74%
Earnings Yield	5.82%
FCF Yield	8.28%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 29, 2020. It was a forward split with a ratio of 4.

Last Split Date	Oct 29, 2020
Split Type	Forward
Split Ratio	4

Scores

Pfizer has an Altman Z-Score of 2.22 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.22
Piotroski F-Score	8